$OVTZ
OCULUS VISIONTECH INC.

2017 Q1 Form 10-Q Financial Statement

#000143774917009083 Filed on May 15, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q1
Revenue $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit $0.00 $0.00
YoY Change -100.0%
Gross Profit Margin
Selling, General & Admin $41.40K $36.69K
YoY Change 12.84% 58.82%
% of Gross Profit
Research & Development $9.005K $55.08K
YoY Change -83.65%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $50.41K $91.76K
YoY Change -45.07% 297.23%
Operating Profit -$50.41K -$91.76K
YoY Change -45.07% 409.06%
Interest Expense $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change -100.0%
Pretax Income -$50.00K -$90.00K
YoY Change -44.44% 200.0%
Income Tax
% Of Pretax Income
Net Earnings -$50.41K -$91.76K
YoY Change -45.07% 264.12%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$1.097K -$1.975K
COMMON SHARES
Basic Shares Outstanding 45.57M 45.57M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.00K $90.00K
YoY Change -88.89%
Cash & Equivalents $5.500K $93.41K
Short-Term Investments
Other Short-Term Assets $60.00K $10.00K
YoY Change 500.0% 0.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $67.69K $101.0K
YoY Change -33.01% 910.37%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $67.69K $101.0K
Total Long-Term Assets $0.00 $0.00
Total Assets $67.69K $101.0K
YoY Change -33.01% 910.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $110.0K $40.00K
YoY Change 175.0% -50.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $439.6K $61.12K
YoY Change 619.36% -94.99%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $439.6K $61.12K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $440.0K $60.00K
YoY Change 633.33% -95.08%
SHAREHOLDERS EQUITY
Retained Earnings -$40.83M -$40.42M
YoY Change 1.02%
Common Stock $40.46M $40.46M
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$372.0K $39.92K
YoY Change
Total Liabilities & Shareholders Equity $67.69K $101.0K
YoY Change -33.01% 910.37%

Cashflow Statement

Concept 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income -$50.41K -$91.76K
YoY Change -45.07% 264.12%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$925.00 -$90.00K
YoY Change -98.97%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -925.0 -90.00K
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash -925.0 -90.00K
YoY Change -98.97%
FREE CASH FLOW
Cash From Operating Activities -$925.00 -$90.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 ovtz Working Capital Deficit
WorkingCapitalDeficit
-371961
CY2017Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
110517
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
120467
CY2017Q1 us-gaap Assets
Assets
67685
CY2016Q4 us-gaap Assets
Assets
68576
CY2017Q1 us-gaap Assets Current
AssetsCurrent
67685
CY2016Q4 us-gaap Assets Current
AssetsCurrent
68576
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5500
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6425
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
187097
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93410
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-925
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-93687
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2016Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45572568
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45572568
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45572568
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45572568
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
40458297
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
40458297
CY2017Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
CY2016Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
CY2017Q1 us-gaap Costs And Expenses
CostsAndExpenses
50405
CY2016Q1 us-gaap Costs And Expenses
CostsAndExpenses
91763
CY2017Q1 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
CY2017Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10473000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10466000
CY2017Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
329129
CY2016Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
269665
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2017Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9950
CY2016Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
20930
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
CY2017Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
59464
CY2016Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-21565
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
34
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1289
CY2017Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
CY2016Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
CY2017Q1 us-gaap Interest Paid
InterestPaid
CY2016Q1 us-gaap Interest Paid
InterestPaid
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
67685
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
68576
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
439646
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
390132
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-925
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-93687
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-50405
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-453240
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-386584
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-91763
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-50405
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-91763
CY2017Q1 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2016Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000000
CY2017Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
62185
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
62151
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9005
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
55075
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-40830258
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-40779853
CY2017Q1 us-gaap Revenues
Revenues
CY2016Q1 us-gaap Revenues
Revenues
CY2017Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
41400
CY2016Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
36688
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
-371961
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-321556
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
45572568
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
45572568

Files In Submission

Name View Source Status
0001437749-17-009083-index-headers.html Edgar Link pending
0001437749-17-009083-index.html Edgar Link pending
0001437749-17-009083.txt Edgar Link pending
0001437749-17-009083-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ovtz-20170331.xml Edgar Link completed
ovtz-20170331.xsd Edgar Link pending
ovtz-20170331_cal.xml Edgar Link unprocessable
ovtz-20170331_def.xml Edgar Link unprocessable
ovtz-20170331_lab.xml Edgar Link unprocessable
ovtz-20170331_pre.xml Edgar Link unprocessable
ovtz20170331_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending